Treating ocular surface disease: New agents in development

Ahmad M. Fahmy, David R. Hardten

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


This paper reviews recent advances and investigation in the treatment of ocular surface pathology. There is significant investment in this area, paralleling the growing demand for more effective alternatives to current treatments. Clinicians are becoming more aware of surface pathology, yet the ability to treat the most common forms of ocular pathology are still limited to the few medications approved by the US Food and Drug Administration. Medicines and devices currently under investigation are very promising. It is absolutely critical to understand the emerging options and think of their role in the treatment paradigm.

Original languageEnglish (US)
Pages (from-to)465-472
Number of pages8
JournalClinical Ophthalmology
Issue number1
StatePublished - May 27 2011


  • Anti-inflammatory drugs
  • Dysfunctional tear syndrome
  • Treatment


Dive into the research topics of 'Treating ocular surface disease: New agents in development'. Together they form a unique fingerprint.

Cite this